Amgen says drug combo cuts risk of death by 58% in patients with aggressive lung cancer

A drug from Amgen could give patients with an aggressive form of lung cancer significantly more time to live when added to an immunotherapy from AstraZeneca.

Published on RocksNews: 24 Oct 2026, 15:15 UTC
Updated: 24 Oct 2026, 15:15 UTC
Language: English

Amgen says drug combo cuts risk of death by 58% in patients with aggressive lung cancer — Amgen says drug combo cuts risk of death by 58% in patients with aggressive lung cancer — Image credit: CNBC – Top News

A drug from Amgen could give patients with an aggressive form of lung cancer significantly more time to live when added to an immunotherapy from AstraZeneca.

Why Israeli tourists and investors are unsettling Cypriots

24 Oct 2026, 15:32 UTC

An ex-bookkeeper spent $375 to launch a sewing business: 'I hadn't felt so sure about something like that in a long time'

24 Oct 2026, 15:15 UTC

I quit my marketing job to walk dogs for 4 months: It's 'one of the most valuable professional experiences I've ever had'

24 Oct 2026, 15:15 UTC

America by the numbers: How voters feel about the economy, inflation, AI and Trump

24 Oct 2026, 14:14 UTC

Ukraine says Starlink and Starshield high speed restrictions have been lifted

24 Oct 2026, 13:13 UTC

Fact vs. fiction: Doctors share whether peptides are safe and effective

24 Oct 2026, 13:13 UTC

Amgen says drug combo cuts risk of death by 58% in patients with aggressive lung cancer | RocksNews